查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587616

到 2030 年人工器官和仿生市场预测：按产品、材料、分销管道、技术、应用、最终用户和地区进行的全球分析

Artificial Organs and Bionic Market Forecasts to 2030 - Global Analysis By Product (Artificial Organs and Bionic Devices), Material (Biomaterials, Metals, Polymers and Ceramics), Distribution Channel, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2024年全球人造器官和仿生市场规模将达到424亿美元，预计2030年将达到807亿美元，预测期内复合年增长率为11.3%。

人造器官是一种旨在重现自然器官功能并为器官衰竭或功能障碍患者提供治疗解决方案的人工装置。另一方面，仿生学是指生物系统和机械部件的集成，通常透过技术增强或恢復人类的能力。这两个领域都旨在提高生活质量，人造器官着重于器官替代，仿生学着重于增强身体表现，代表了医学和工程学的重要进步。

根据 HRSA 的数据，2022 年，65 岁及以上族群进行了 8,895 例器官移植手术，比 2021 年增加了 3.7%，达到 42,887 例。

器官移植需求不断成长

器官移植需求的不断增长正在显着推动市场发展。慢性疾病增加、人口老化和捐赠器官严重短缺等因素强调需要创新解决方案。人造器官为患者提供了重要的替代方案，仿生技术正在提高移动性和功能性。需求的激增正在推动旨在改善患者治疗效果和扩大可用治疗方法范围的进步。

监管挑战

市场上的监管挑战包括严格的核准流程，以确保产品到达消费者之前的安全性和有效性。了解 FDA 等机构的复杂指导方针可能会减缓创新和市场进入。此外，各国的法规各不相同，使得全球合作和标准化变得复杂。这些障碍可能会阻碍救生技术的快速发展，因此相关人员必须与监管机构合作，在保持安全标准的同时简化流程。

慢性病增加

糖尿病、心臟病和肾衰竭等慢性病的盛行率不断上升，推动了市场需求。由于这些疾病导致器官功能障碍，对人造器官和仿生设备等创新解决方案的需求变得更加重要。这一趋势凸显了技术进步对于加强患者护理、提高生活品质以及应对日益增长的慢性健康问题人口带来的挑战的重要性。

有限的外科专业知识

有限的外科专业知识是这个市场的主要挑战。植入和管理先进技术的复杂性需要高度专业化的技能，而这些技能可能无法广泛使用，特别是在服务不足的地区。这种短缺可能会导致患者无法获得紧急医疗设备，从而阻碍整体市场成长。透过有针对性的培训和教育来弥补这一差距对于提高手术能力和改善患者治疗效果至关重要。

COVID-19 的影响

COVID-19 大流行扰乱了供应链并推迟了研发计划，对市场产生了重大影响。医院优先考虑急性护理，导致涉及义肢装置的选择性手术被推迟。然而，这场大流行加速了人们对创新医疗解决方案的兴趣，并凸显了对先进技术来解决病毒加剧的慢性疾病的需求。随着医疗保健优先事项的发展，这种变化可能会推动该领域的未来成长和投资。

生物工程领域预计将在预测期内成为最大的领域

由于慢性病和器官短缺的增加，生物工程领域预计将在预测期内占据最大的市场占有率。这些创新旨在模仿自然器官功能，同时解决器官稀缺和排斥等问题。透过将生物材料和工程原理相结合，生物工程产品提供了个人化医疗的潜力，改善了患者的治疗效果，并为再生医学中更有效的治疗铺平了道路。

预计医院领域在预测期内的复合年增长率最高。

预计医院部门在预测期内将呈现最高的复合年增长率。医院对于临床测试至关重要，新技术在这里得到测试和改进。此外，医院越来越多地部署先进的人造器官和仿生设备来改善治疗效果，尤其是慢性病患者。这一趋势推动了对创新解决方案的需求，并凸显了医院在医疗技术进步中的关键地位。

比最大的地区

由于先进的医疗基础设施、高额研发投资以及慢性病发病率上升，预计北美地区将在预测期内占据最大的市场占有率。主要企业和创新新兴企业处于技术进步的最前沿，专注于人造器官和仿生设备。此外，支持性的政府政策以及对患者护理和个人化医疗的大力关注正在进一步支持该地区的市场扩张。

复合年增长率最高的地区

在残障人士人数增加的推动下，预计亚太地区在预测期内将实现最高成长率。该市场包括心臟和肾臟等人造器官以及人工电子耳和整形外科仿生等仿生设备等各个领域。医疗机构、大学和私人公司之间为增强产品供应和改善患者治疗效果而进行的合作进一步推动了对这些创新的需求。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 按产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球人造器官与仿生市场：副产品

  • 介绍
  • 人造器官
    • 人工胰臟
    • 人工心臟
    • 人工肺
    • 人工肾
    • 人工肝
  • 仿生装置
    • 义肢
    • 仿生眼
    • 人工电子耳
    • 神经介面

第六章全球人造器官与仿生市场：依材料分类

  • 介绍
  • 生物材料
  • 金属
  • 聚合物
  • 陶瓷製品

第七章全球人造器官与仿生市场：依通路划分

  • 介绍
  • 直销
  • 第三方卖家
  • 网路平台

第八章全球人造器官与仿生市场：依技术分类

  • 介绍
  • 传统的
  • 生物工程
  • 再生医学
  • 基于奈米科技
  • 其他的

第九章全球人造器官与仿生市场：依应用分类

  • 介绍
  • 慢性病
  • 外伤和损伤
  • 整容手术
  • 神经假体
  • 其他的

第十章全球人造器官和仿生市场：依最终用户分类

  • 介绍
  • 医院
  • 门诊手术中心
  • 居家医疗
  • 復健中心
  • 其他的

第十一章全球人造器官与仿生市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第十二章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十三章 公司概况

  • Medtronic Plc.
  • Boston Scientific Corporation
  • IVIVA Medical
  • SynCardia Systems, LLC
  • Ekso Bionics
  • Edwards Lifesciences Corporation
  • ABIOMED
  • Berlin Heart
  • Cochlear Ltd.
  • Jarvik Heart, Inc
  • Zimmer Biomet
  • Smith & Nephew
  • Kangaroo Health
  • Cyberdyne
  • Hanger Clinic
Product Code: SMRC27601

According to Stratistics MRC, the Global Artificial Organs and Bionic Market is accounted for $42.4 billion in 2024 and is expected to reach $80.7 billion by 2030 growing at a CAGR of 11.3% during the forecast period. Artificial organs are engineered devices designed to replicate the functions of natural organs, providing therapeutic solutions for individuals with organ failure or dysfunction. Bionics, on the other hand, refers to the integration of biological systems with mechanical components, often enhancing or restoring human capabilities through technology. Both fields aim to improve quality of life, with artificial organs focusing on organ replacement and bionics enhancing physical abilities, representing significant advancements in medical science and engineering.

According to the HRSA, in 2022, there were 8,895 organ transplant procedures performed on the population aged over 65 in the U.S. In 2022, 42,887 organ transplants were performed in the U.S., an increase of 3.7 percent over 2021.

Market Dynamics:

Driver:

Increasing demand for organ transplants

The growing demand for organ transplants is significantly boosting the market. Factors such as rising chronic diseases, an aging population, and a critical shortage of donor organs underscore the need for innovative solutions. Artificial organs provide vital alternatives for patients, while bionic technologies enhance mobility and functionality. This surge in demand is driving advancements aimed at improving patient outcomes and expanding the range of available treatments.

Restraint:

Regulatory challenges

Regulatory challenges in the market include stringent approval processes, ensuring safety and efficacy before products reach consumers. Navigating complex guidelines from agencies like the FDA can delay innovation and market entry. Additionally, varying regulations across countries complicate global collaboration and standardization. These hurdles can hinder the rapid development of life-saving technologies, making it essential for stakeholders to engage with regulators to streamline processes while maintaining safety standards.

Opportunity:

Growing incidence of chronic diseases

The increasing incidence of chronic diseases, such as diabetes, heart disease, and kidney failure, is driving demand in the market. As these conditions lead to organ dysfunction, the need for innovative solutions like artificial organs and bionic devices becomes more critical. This trend emphasizes the importance of technological advancements to enhance patient care, improve quality of life, and address the challenges posed by a growing population living with chronic health issues.

Threat:

Limited surgical expertise

Limited surgical expertise poses a significant challenge in the market. The complexity of implanting and managing advanced technologies requires highly specialized skills that may not be widely available, particularly in underserved regions. This shortage can lead to delays in patient access to life-saving devices and hinder the overall growth of the market. Addressing this gap through targeted training and education is crucial for enhancing surgical capabilities and improving patient outcomes.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the market by disrupting supply chains and delaying research and development projects. Hospitals prioritized acute care, leading to postponed elective surgeries, including those involving artificial devices. However, the pandemic also accelerated interest in innovative healthcare solutions, highlighting the need for advanced technologies to address chronic conditions exacerbated by the virus. This shift may drive future growth and investment in the sector as healthcare priorities evolve.

The bioengineered segment is projected to be the largest during the forecast period

The bioengineered segment is projected to account for the largest market share during the projection period due to rising chronic diseases and organ shortages. These innovations aim to mimic natural organ functions while addressing issues like organ shortage and rejection. By combining biological materials with engineering principles, bioengineered products offer the potential for personalized medicine, enhancing patient outcomes and paving the way for more effective treatments in regenerative medicine.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is expected to have the highest CAGR during the extrapolated period. They are essential for clinical trials, where new technologies are tested and refined. Furthermore, hospitals are increasingly adopting advanced artificial organs and bionic devices to improve patient outcomes, particularly for those with chronic conditions. This trend drives demand for innovative solutions, highlighting hospitals' pivotal position in advancing medical technology.

Region with largest share:

North America region is projected to account for the largest market share during the forecast period driven by advanced healthcare infrastructure, significant investments in research and development, and increasing prevalence of chronic diseases. Leading companies and innovative startups are at the forefront of technological advancements, focusing on artificial organs and bionic devices. Additionally, supportive government policies and a strong emphasis on patient care and personalized medicine are further propelling market expansion in the region.

Region with highest CAGR:

Asia Pacific is expected to register the highest growth rate over the forecast period driven by an increasing incidence of disabilities. The market encompasses various segments, including artificial organs like hearts and kidneys, as well as bionic devices such as cochlear implants and orthopedic bionics. The demand for these innovations is further fueled by collaborative efforts among healthcare institutions, universities, and private companies to enhance product offerings and improve patient outcomes

Key players in the market

Some of the key players in Artificial Organs and Bionic market include Medtronic Plc., Boston Scientific Corporation, IVIVA Medical, SynCardia Systems, LLC, Ekso Bionics, Edwards Lifesciences Corporation, ABIOMED, Berlin Heart, Cochlear Ltd., Jarvik Heart, Inc, Zimmer Biomet, Smith & Nephew, Kangaroo Health, Cyberdyne and Hanger Clinic.

Key Developments:

In May 2024, Medtronic Plc. acquired Aortix, a company specializing in advanced circulatory support technologies, to expand its portfolio in artificial organ systems. This acquisition is expected to enhance Medtronic's capabilities in providing innovative solutions for patients with severe cardiac conditions.

In April 2024, Zimmer Biomet Holdings, Inc. announced the successful completion of the world's first robotic-assisted shoulder replacement surgery using its ROSA(R) Shoulder System. The surgery was performed at Mayo Clinic by John W. Sperling, MD, MBA, Professor of Orthopedic Surgery at Mayo Clinic in Rochester, Minnesota, and a key contributor to the ROSA Shoulder development team.

Products Covered:

  • Artificial Organs
  • Bionic Devices

Materials Covered:

  • Biomaterials
  • Metals
  • Polymers
  • Ceramics

Distribution Channels Covered:

  • Direct Sales
  • Third-Party Distributors
  • Online Platforms

Technologies Covered:

  • Conventional
  • Bioengineered
  • Regenerative Medicine
  • Nanotechnology-Based
  • Other Technologies

Applications Covered:

  • Chronic Diseases
  • Trauma and Injury
  • Cosmetic and Aesthetic Procedures
  • Neuroprosthetics
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Rehabilitation Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Artificial Organs and Bionic Market, By Product

  • 5.1 Introduction
  • 5.2 Artificial Organs
    • 5.2.1 Artificial Pancreas
    • 5.2.2 Artificial Heart
    • 5.2.3 Artificial Lungs
    • 5.2.4 Artificial Kidney
    • 5.2.5 Artificial Liver
  • 5.3 Bionic Devices
    • 5.3.1 Prosthetic Limbs
    • 5.3.2 Bionic Eyes
    • 5.3.3 Cochlear Implants
    • 5.3.4 Neural Interfaces

6 Global Artificial Organs and Bionic Market, By Material

  • 6.1 Introduction
  • 6.2 Biomaterials
  • 6.3 Metals
  • 6.4 Polymers
  • 6.5 Ceramics

7 Global Artificial Organs and Bionic Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Third-Party Distributors
  • 7.4 Online Platforms

8 Global Artificial Organs and Bionic Market, By Technology

  • 8.1 Introduction
  • 8.2 Conventional
  • 8.3 Bioengineered
  • 8.4 Regenerative Medicine
  • 8.5 Nanotechnology-Based
  • 8.6 Other Technologies

9 Global Artificial Organs and Bionic Market, By Application

  • 9.1 Introduction
  • 9.2 Chronic Diseases
  • 9.3 Trauma and Injury
  • 9.4 Cosmetic and Aesthetic Procedures
  • 9.5 Neuroprosthetics
  • 9.6 Other Applications

10 Global Artificial Organs and Bionic Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Ambulatory Surgical Centers
  • 10.4 Homecare Settings
  • 10.5 Rehabilitation Centers
  • 10.6 Other End Users

11 Global Artificial Organs and Bionic Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Medtronic Plc.
  • 13.2 Boston Scientific Corporation
  • 13.3 IVIVA Medical
  • 13.4 SynCardia Systems, LLC
  • 13.5 Ekso Bionics
  • 13.6 Edwards Lifesciences Corporation
  • 13.7 ABIOMED
  • 13.8 Berlin Heart
  • 13.9 Cochlear Ltd.
  • 13.10 Jarvik Heart, Inc
  • 13.11 Zimmer Biomet
  • 13.12 Smith & Nephew
  • 13.13 Kangaroo Health
  • 13.14 Cyberdyne
  • 13.15 Hanger Clinic

List of Tables

  • Table 1 Global Artificial Organs and Bionic Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Artificial Organs and Bionic Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Artificial Organs and Bionic Market Outlook, By Artificial Organs (2022-2030) ($MN)
  • Table 4 Global Artificial Organs and Bionic Market Outlook, By Artificial Pancreas (2022-2030) ($MN)
  • Table 5 Global Artificial Organs and Bionic Market Outlook, By Artificial Heart (2022-2030) ($MN)
  • Table 6 Global Artificial Organs and Bionic Market Outlook, By Artificial Lungs (2022-2030) ($MN)
  • Table 7 Global Artificial Organs and Bionic Market Outlook, By Artificial Kidney (2022-2030) ($MN)
  • Table 8 Global Artificial Organs and Bionic Market Outlook, By Artificial Liver (2022-2030) ($MN)
  • Table 9 Global Artificial Organs and Bionic Market Outlook, By Bionic Devices (2022-2030) ($MN)
  • Table 10 Global Artificial Organs and Bionic Market Outlook, By Prosthetic Limbs (2022-2030) ($MN)
  • Table 11 Global Artificial Organs and Bionic Market Outlook, By Bionic Eyes (2022-2030) ($MN)
  • Table 12 Global Artificial Organs and Bionic Market Outlook, By Cochlear Implants (2022-2030) ($MN)
  • Table 13 Global Artificial Organs and Bionic Market Outlook, By Neural Interfaces (2022-2030) ($MN)
  • Table 14 Global Artificial Organs and Bionic Market Outlook, By Material (2022-2030) ($MN)
  • Table 15 Global Artificial Organs and Bionic Market Outlook, By Biomaterials (2022-2030) ($MN)
  • Table 16 Global Artificial Organs and Bionic Market Outlook, By Metals (2022-2030) ($MN)
  • Table 17 Global Artificial Organs and Bionic Market Outlook, By Polymers (2022-2030) ($MN)
  • Table 18 Global Artificial Organs and Bionic Market Outlook, By Ceramics (2022-2030) ($MN)
  • Table 19 Global Artificial Organs and Bionic Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 20 Global Artificial Organs and Bionic Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 21 Global Artificial Organs and Bionic Market Outlook, By Third-Party Distributors (2022-2030) ($MN)
  • Table 22 Global Artificial Organs and Bionic Market Outlook, By Online Platforms (2022-2030) ($MN)
  • Table 23 Global Artificial Organs and Bionic Market Outlook, By Technology (2022-2030) ($MN)
  • Table 24 Global Artificial Organs and Bionic Market Outlook, By Conventional (2022-2030) ($MN)
  • Table 25 Global Artificial Organs and Bionic Market Outlook, By Bioengineered (2022-2030) ($MN)
  • Table 26 Global Artificial Organs and Bionic Market Outlook, By Regenerative Medicine (2022-2030) ($MN)
  • Table 27 Global Artificial Organs and Bionic Market Outlook, By Nanotechnology-Based (2022-2030) ($MN)
  • Table 28 Global Artificial Organs and Bionic Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 29 Global Artificial Organs and Bionic Market Outlook, By Application (2022-2030) ($MN)
  • Table 30 Global Artificial Organs and Bionic Market Outlook, By Chronic Diseases (2022-2030) ($MN)
  • Table 31 Global Artificial Organs and Bionic Market Outlook, By Trauma and Injury (2022-2030) ($MN)
  • Table 32 Global Artificial Organs and Bionic Market Outlook, By Cosmetic and Aesthetic Procedures (2022-2030) ($MN)
  • Table 33 Global Artificial Organs and Bionic Market Outlook, By Neuroprosthetics (2022-2030) ($MN)
  • Table 34 Global Artificial Organs and Bionic Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 35 Global Artificial Organs and Bionic Market Outlook, By End User (2022-2030) ($MN)
  • Table 36 Global Artificial Organs and Bionic Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 37 Global Artificial Organs and Bionic Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 38 Global Artificial Organs and Bionic Market Outlook, By Homecare Settings (2022-2030) ($MN)
  • Table 39 Global Artificial Organs and Bionic Market Outlook, By Rehabilitation Centers (2022-2030) ($MN)
  • Table 40 Global Artificial Organs and Bionic Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.